StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bearish analyst signal: the lowered target is below the posted price, although the implied downside is moderate and the rationale is unavailable.
What happened, with direct paths to the underlying reporting
Needham lowered its price target for Veracyte to $46, below the posted price of $52.52, implying roughly 12% downside to the revised target. No rationale or rating was provided.
Target: $46
Posted price: $52.52
Analyst firm: Needham
Analyst: Mike Matson
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.